bortezomib will raise the stage or impact of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Elevated flibanserin adverse results may possibly manifest if coadministered with numerous weak CYP3A4 inhibitors.Display for hepatitis B virus in all cancer sufferers setting up systemic therapy. Figure out more a